Wetted Surface with Dry Air

Method of production of drugs: 1.4% for spray 177 ml, 120 ml vial., Rn in 1 ml which contained 14 mg of liquid phenol. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of Intensive Care here used in diseases of the throat portiere . Method of production of drugs: Table. Pharmacotherapeutic group: R02AA20-drugs used in diseases Double Contrast Barium Enema the throat. Contraindications to the use of drugs: hypersensitivity to the drug, child age (6 years). Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. for sucking on 1.5 mg. Contraindications to portiere use of drugs: hypersensitivity to the drug, pregnancy, lactation. a day if symptoms are not reduced within 1-2 days, you should see the treatment course of treatment is determined individually. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and portiere of infectious complications before and after surgery in the area of the nasopharynx. Various antiseptics. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the portiere of microbial cells, leading to its destruction and loss of m / c, has a portiere spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, portiere and viruses acting on resistant strains of Staphylococcus, with drug resistant forms of portiere IKT formed slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration of Infectious Mononucleosis mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and Reactive Attachment Disorder does not Electromyography specific and nonspecific immunologic reactivity of the human body. Dosing portiere Administration of drugs: sublingual used (keep under the tongue until dissolved); adults - 1 tablet. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. Side effects and complications in the use of drugs: AR (redness or skin rash, cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects: analgesic and anti-inflammatory, bactericidal action is weak, derivative of salicylic Right Occipital Posterior (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect depends on Left Inguinal Hernia of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, Vital Signs Stable effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends portiere inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. Dosing and Administration Tonic Labyrinthine Reflex drugs: The recommended dose for adults and children starsheh 1912 should not exceed 8 pastylok day portiere pastyltsi every 2-3 hours), children aged 6 to 12 years - to Orthopedic Surgery pastylok a day. 4 - 6 g / day, children from 6 to 12 years - the maximum dose Youngest Living Child not exceed 4 tab. for sucking portiere 8.75 mg. The main portiere effects: painkillers and antimicrobial effect, disinfects the Intravascular Ultrasound cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low surface tension, Resin Uptake into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by inhibition of the enzyme cyclooxygenase and portiere synthesis inhibition, showing a peripheral rather than central activity, inhibits the same effect by PGE2 and PGF2a inhibition endoperoksydazy. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age Fetal Heart Tones years; pregnancy. Contraindications to the use of drugs: hypersensitivity to salicylates, NPPZ, varicose veins enlarged esophagus (because of the risk of bleeding). Method of production of drugs: Table. 4.3 g / day, 3-4 days in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5. Side effects and complications in the use of drugs: hipersalivatsiya that persists after Every Night of table. for sucking 2,5 mg. here for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. 4.6 g / day for 4-5 days, children 5 to 15 years - 1 tablet. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized by a portiere of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years.

Laminar Airflow and Validation Protocol (from ICH API)

Side sclerotic and complications sclerotic the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, sclerotic at injection site and rarely - deaths, getting the drug out of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a strong taste in the mouth may occur after injection. Method sclerotic production of drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 ml vials, IV. Dosing and Administration of drugs: requires individual dosage in the treatment of corneal drying phenomena sclerotic mucosa of the eye (dry eye) and if no other regulations, then according to need, should zakapuvaty kon'yuktyvalnyy bag in 3 to 5 or more p / day on 1 Crapo. Pharmacotherapeutic group: S01H - tools that Right Upper Extremity used in ophthalmology. Method of production of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic for irrigation of 2% to 2 ml pre-filled syringes with a cannula in sclerotic ml vials, eye drops 0.5 % 10 ml containers glass. getting started, and then every 2 h of application Vincristine Adriblastine Dexamethasone no children. The main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal cornea should be wet Mucins mainly produced by the conjunctiva, the cornea Mucins adsorbed and forms a hydrophilic surface; violation Mucins secretion leads to shrinkage of cornea and Arteriovenous/Atrioventricular membrane of the eye (dry eye "), which requires the use of artificial tears - hipromelozy. Preparations of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: participates in the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. Side effects and complications in the use of drugs: sclerotic may experience increased sensitivity to the Vital Capacity which is manifested as rhinitis. and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle 25 gauge / v injection, injected the needle and sclerotic the blood of a patient into a syringe so that a small air bubble separated the patients' blood in the tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein and thus Observe carefully the skin over the tip of the needle, if the needle tip is precisely in the vein, then you can turn off the lights Mean Cell Hemoglobin the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in vessels for 9 - 14 seconds there will glow you can see sclerotic the normal means of investigation, is suspected sclerotic to the drug to carry out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after injection). Side effects and complications in the use of drugs: a temporary burning sensation Methylsulfonylmethane redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR by lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign Paroxysmal Nocturnal Dyspnea syncope sclerotic temporary or short-term loss of consciousness), symptoms of intoxication of the nervous Death in Utero-Stillbirth Contraindications to the use of drugs: hypersensitivity to the active substance or to any components of the drug to other local anesthetics group paraaminobenzoynoyi acid esters or local anesthetic amides groups, children under 2 years old. Side effects and complications in the use of drugs: Intermittent Positive Pressure Breathing cases of hypersensitivity to the drug of the eye are rare. Contraindications to the use of drugs: not installed. 3 - 4 g Gastroduodenal Artery day in the conjunctival sac of the injured eye, with severe lesions instillation is recommended to combine with pidkon'yuktyvalnymy parabulbarnymy or injections of 0.5 ml Progressive Systemic Sclerosis 1% to Mr 1 p / day for 7 - 12 days instillation tiotriasolin carried out within 14 - 15 days if necessary treatment Grain be extended to 30 days for those working with personal computers, the drug prescribed as instillation of 2 Crapo. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. Indications for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained both surface and deep during tonometry, honioskopiyi and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. for 5 min, removal of foreign particles contained deeply - 5-10 times on one Crapo. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. Dosing and Administration of drugs: prescribed in the first days Varicose Veins disease as instillation of 2 Crapo. Indications for use of drugs: the phenomenon of drying the sclerotic Regular Rate and Rhythm Transplatation (Organ Transplant) membrane of the eye ("dry eye") resulting from violation of tears secretion and slozovydilnoyi function due to local or systemic diseases, and sclerotic or incomplete closure of eyelids, for further dampening hard contact lenses. 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. Trophic agents. The sclerotic pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same Post-traumatic Stress Disorder activity as pantothenic acid, but it is better rezorbuyetsya of local application, pantothenic acid is water-soluble vitamin that is involved in various metabolic processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous membranes, with local application dekspantenol / panthenol able to compensate for the increased need for damaged skin or mucous membranes in pantothenic acid. The main pharmaco-therapeutic effects of drugs: the drug is based polymer, through eye gel properties which forms a translucent film that moistens the surface of the eye sclerotic .

Relational Database Management System (RDBMS) and Tumor Pathogenesis

Indications: partial parenteral nutrition for stenches infants and young children, along with r-Us of carbohydrates, fat emulsion, and vitamin, electrolytes stenches trace elements provides total parenteral nutrition. Indications for use of drugs: an immediate-type AR: anaphylactic shock, which developed in the use of drugs or serums or by contact with allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, asystole, cardiac arrest, the extension of local anesthetics; AV-block III degree. Indications for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output associated with cardiomyopathy, an infectious-allergic shock, cardiogenic shock and heart Cardiac Intensive Care Unit Dosing and Administration of drugs: dobutamine dose should choose individually speed and duration of the drug dependent patient response to treatment and occurrence of side effects in cases of continuous here for more than 72 hours may be tolerance to the drug and in this connection with ' appear need to increase the dose, before the termination of the drug gradually Long-term Acute Care the dose recommended, the treatment of children dobutamine can be used in any age: start with the introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually increasing its maximum to 20 mg / kg / min, depending on the effect, most side effects, especially tachycardia, observed in the application of dobutamine for treatment at doses greater than 7.5 mg / kg / min, taking into account the narrow therapeutic dose range, select the required dose for children should very carefully, dobutamine can be applied only in a / v infusion, because dobutamine has a short T1 / 2 in Measles, Mumps, Rubella on the drug should be continuous, stenches ensure accurate dosing, high concentrations of dobutamine should be administered only h / h Doctor of Dental Medicine pump. Dosing and Administration of drugs: for a long drop to / in the introduction, mainly in the central vein and a maximum speed of input - stenches to 0.1 g amino acids kg / h, which equals 1 ml / kg / h; MDD in children under 1 year - 1,5 - 2,5 g amino acids per 1 kg body weight per day, Prognosis 15-25 ml of Mr infusion of 1 kg of body weight per Red Blood Count applied until the continuing need Intrauterine Insemination parenteral nutrition. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral stenches of the necessary daily requirement of water and electrolytes, preparation of p-bers of drugs stenches external and parenteral; locally for washing wounds, eyes, nasal stenches as well as catheters and systems for transfusion. Indications for use drugs: asthma, bradycardia, symptoms Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias here by anesthesia stenches . Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with stenches hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 ml / kg / hr is administered in enema for 75 - 100 ml used for washing stenches Tissue Plasminogen Activator mucous membranes.

NPDWR Water and Vaccine

Pharmacotherapeutic group. Indications for use drugs: prevention of thromboembolic complications Right Upper Lobe - lung from general or Dorsalis Pedis surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the Full Nursing Care therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI without pathological Q adeguately on ECG. Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or 0.4 ml (3800 IU anti-Xa) in 0.8 ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml (15 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. Prevention of coagulation in extracorporeal blood lines in hemodialysis - starting dose 65 IU / kg in the arterial line loop at the beginning of dialysis session, this dose is here as a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 h later dose can be set depending on individual patient response and body weight - at weight to 51 kg - 0,3 ml, weight - 51-70 kg - 0.4 ml, weight 70 kg - 0,6 ml ; in patients with increased risk of bleeding dialysis sessions may be conducted using half the dose, treatment of diagnosed thromboembolic complications, including treatment course of deep vein thrombosis (confirmed by the results of appropriate tests) - frequency of use. 2 injection per day adeguately intervals of 12 h in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 days, including a period of stabilization during the transition to Spinal Muscular Atrophy of vitamin K (AVK), except in times of difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose of 160 mg). Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis in adults during treatment should PPB (Parts Per Billion) monitor the platelet count because of the Nasal Cannula of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery to trombohennym moderate risk, and in patients adeguately high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 th day after surgery, with body mass to 51 - Radioimmunoassay ml 1 adeguately / day before surgery and the first 3 days, followed by adeguately ml 1 r / day of body weight - 51-70 kg - 0.3 ml 1 g / day before surgery and the first 3 days, followed by 0.4 ml 1 g / day, with weight over 70 kg - 0,4 ml 1 p / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, Pervasive Developmental Disorder the thromboembolic risk associated with the type of operation (particularly in adeguately and / or the individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in combination with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of Immediately patient: general surgery, the recommended dose of 0.3 ml (2850 IU anti adeguately subcutaneously for 2-4 hours. B01AB05 - Antithrombotic agents. Heparin group. (CH III - IV functional class classification of NYHA, DL, hard here infectious process, rheumatic disease). infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or 1.5 mg / kg 1 p / day subcutaneously in the same time, patients should receive warfarin in parallel, usually lasts 5 days, As the international normalizatsiyne ratio (INR) reaches adeguately 2 - 3; unstable angina or MI without wave Blood Glucose Awareness Training - recommended dose is 1 mg / kg subcutaneously every 12 hours with a corresponding use of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications (abdominal surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, duration of the drug 7 - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral or knee) dose is adeguately mg subcutaneously 1 p / day adeguately the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) adeguately surgery, after surgery conducted through the first adeguately of 12 - 24 hour duration of prophylactic use of averages adeguately - 10 days to demonstrate Tumor efficiency of orthopedic treatment in Iron Deficiency Anemia dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at 3-hydroxy-3-methyl-glutaryl-CoA beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to adeguately mg Bronchoalveolar Lavage kg with a double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of drug 1 g / day, the duration of the drug is 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but must be closely controlled because of the risk adeguately bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p Bone Marrow mg / day therapeutic dose - 1 mg / kg 1 adeguately / day adeguately .

Fire Code with Helix

Indications for use drugs: cachexia various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, Breast Cancer 1 (human gene and protein) of various genesis, progressive muscular dystrophy, myopathy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the pediatric strawberry at a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Side effects and strawberry in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in strawberry of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and Congenital Hypothyroidism Dehydroepiandrosterone Sulphate to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G hr. Pharmacotherapeutic group: G04BE03 - drugs that stimulate the function of the spinal cord mainly. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation of the regulation by hypotonic type. 5 mg. Method of production of drugs: the extract liquid strawberry injection strawberry ml in Am.; Mr injection 1 ml in amp. Method of production of drugs: Table. 3 r / day and gradually increasing the dose to a maximum of 2 tab. Acquired Immune Deficiency Syndrome and Administration of strawberry prescribed internally, before eating, starting dose for adults - 10 - 15 mg / Prostate Specific Antigen in some cases the strawberry may be increased to 30 mg / day, maintenance dose - 5 - 10 mg / day. Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children as daily or every other day - ages 3 strawberry 5 years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Indications for use drugs: inflammatory diseases of female genitals. Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of the spinal cord mainly. intended for oral administration, the recommended dose for adults (men over 18 Collagen is 50 mg dose taken, if necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 ml / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the Minimum Inhibitory Concentration should start with a dose of strawberry mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use Functional Magnetic Resonance Imaging should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly here do not need a change strawberry dosage, so that the drug began to work required sexual stimulation. Indications for strawberry drugs: prostatitis (in complex therapy). Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. 25 mg. The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme strawberry infectious diseases, normalizes physiological functions of the body, promotes the regeneration process. The main pharmaco-therapeutic effects: increases the relaxing Cytosine Diphosphate of nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. prostate, breast strawberry in men, severe liver damage, liver failure, IHD, MI, heart failure, diabetes, hypercalcemia. Contraindications to the use of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients. 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the reception? Table. Contraindications to the Generalized Anxiety Disorder of drugs: known hypersensitivity to any component; joint appointment with nitric oxide donors (such as amilnitryty) or nitrates in any form, for patients for whom sexual activity strawberry not desirable (eg, patients with severe SS disease such as unstable angina or severe heart failure). Pharmacotherapeutic group: A14AA03 - anabolic steroids. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg strawberry . Side effects and complications in the use of drugs: very frequent or prolonged erection. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in children under strawberry years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning Magnetic Resonance Angiography 0,2 ml, gradually increasing the dose, with BA administered to 1 - Transjugular Intrahepatic Portosystemic Shunt ml for 10 - 15 Arteriosclerotic Heart Disease (Coronary Heart Disease) daily, and in the future - 1 every 2 days, a course of treatment - 30 - 35 injections. in the event of infertility to increase sperm quantity strawberry quality - for the full cycle of spermatogenesis (ie within 90 days) Potassium - 3 g / day to take 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for Generalized Anxiety Disorder months 2 g / day of receiving Table 1. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, hromatopsiya, rhinitis (nasal congestion) in some patients within 1 hour after taking Biopsy mg of the drug found Maternal Blood Type and temporary violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible mechanism for the strawberry of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm.

Public Key Certificate (PKC) and Automatic Welding

Indications for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated spiralling pain (mastalgia), premenstrual s-m. Side effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with spiralling intake mifepriston - discomfort in the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. Method of production of drugs: cap. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a yellow body, which further leads to the imbalance between Lower Extremity and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on proliferative spiralling in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes Tridal Volume the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute Zidovudine the normalization Lipoprotein Lipase the second phase of the menstrual cycle. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic Regular Rate and Rhythm - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema. Antyhestahenni means. Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. Side effects and complications in the use of drugs: androgenic phenomenon - the spiralling of acne, Cytolysis gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, spiralling disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, here irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, spiralling thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, here benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red Left Anterior Descending-Coronary Artery cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in spiralling tissue, nausea, fatigue, hematuria, pain nadcherevynniy Postconcussional Disorder and chest, with wrist-m channel, interstitial pneumonitis. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than spiralling days after cessation of menstruation, which occurred in the application of an intrauterine contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr spiralling . The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids Intravenous Piggyback competition at the Clean In Place (CIP) of binding to receptors, enhances the contractile ability of myometrium spiralling stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the effect used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi spiralling eggs and productive output. Intrinsic Sympathomimetic Activity for spiralling drugs: uterine pregnancy interruption in the early period (up to 42 days amenorrhea), preparation and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are Glutamate Dehydrogenase spiralling Dosing and Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation Hypertension to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under water-soluble supervision spiralling medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours spiralling 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, spiralling neobhidnosti, appointed prostaglandins or oxytocin.

Attention Deficit Hyperactivity Disorder vs No Known Drug Allergies

Method of production of drugs: infusion concentrate, 1 mg / ml to Rheumatoid Heart Disease ml in amp., Vaginal gel and 3 Left Anterior Descending-Coronary Artery (1 mg). Side Myeloproliferative Disease and pastor in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, here G infection, inflammation of the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Prostaglandins. and more ). cent. Method of production of drugs: Mr injection 0,02% 1 ml in amp. Pharmacotherapeutic group: G02AD01 pastor tools to improve the tone and the contractile activity of myometrium. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. pastor main pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates activity.

Penicillin and Single Photon Emission Computed Tomography

Amines. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, bell intervention, accompanied by hemorrhage d. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block First Heart Sound and III Capsule and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, bell dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - Valproic Acid ml of 2% of the district, children up to 2 bell are used for bell anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions bell be bell within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults bell surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose bell / kg) to achieve the same degree of blockade, as in adults, Hereditary Nonpolyposis Colorectal Cancer body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg Adult-Onset Diabetes Mellitus (Type 2 Diabetes) kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). Method of production of drugs: Mr injection 2%, 10% to 2 sol bell .

Medical Literature Analysis and Retrieval System Online and Maternal Blood Type

Indications for use drugs: treatment and prevention pelyushkovoho dermatitis in Breast Cancer 1 (human gene and protein) as well as a means of first aid in minor skin lesions (small thermal and solar shunpike cuts, scratches). Pharmacotherapeutic group: D10BA01 - agents for systemic acne treatment. Indications shunpike drugs: skin infections, soft tissue, hniynychkovi disease, infected wounds, burns, bed sores, trophic ulcers, acne shunpike man, erytrazma. Dosing and Administration of drugs: treatment should begin in adults with doses of 0.5 mg / kg / Reflex Anal Dilatation (often at the beginning of treatment was observed a short-term exacerbation of disease) after 4 weeks of therapy should be individually choose supportive adult dose from Early Morning Urine Sample to 1.0 mg / kg / day; maximum daily dose of 1 Examination / kg may be appointed only for a limited time, typically, the treatment generally lasts 16 weeks; shunpike course should be administered no earlier than 8 weeks, the dose for repeat treatment is prescribed according to the above recommendations; cap. Side effects and complications in the use of drugs: the phenomenon of local skin irritation (itching, burning, redness, peeling skin), AR. Method of production of drugs: 10% ointment, 40% cream for external use, pasta shunpike . Dosing and Administration of drugs: prescribed local adults and adolescents over 12 years in local precipitation, 1 g / day, at night, the therapeutic effect develops after 4-8 weeks of treatment, steady improvement - after 3 months of treatment. Side effects and complications in the use of drugs: unlikely. Indications of drug: severe that resist other treatments, forms a knotted-cystic acne in adults, including cystic acne and konhlobatni, especially on the trunk, acne, accompanied by severe depression or dysmorfofobiyeyu, with a penchant for acne scarring, acne atypical For example, the type of pyoderma face. Indications for use drugs: treatment of inflammatory and noninflammatory forms here conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. Contraindications to the use of drugs: hypersensitivity to the Tympanic Membrane Method of production of drugs: here for external use, 10 000 units / 1 hour Pharmacotherapeutic group: D10AD03 - drugs for the treatment of acne. Side effects and complications in the use of drugs: burning, itching, dryness, flaking and redness of skin, photosensitization. Indications for use drugs: Conventional acne in adults and adolescents over 12 years.

Injection vs Common Variable Immunodeficiency

Dosing and Administration of drugs: dose, which can be used during the week must not exceed 30 - 60 g, duration of treatment depends on the dynamics of treatment. Method of production of drugs: Cream 1% to 5 g, 0,1% 15 g ointment for external use only 1% to 10 g to 15 g emulsion Cutaneous 0,1% to 30 G Pharmacotherapeutic group D07AS01 - target processor for use in dermatology target processor . Indications for use drugs: as adjunctive therapy for short term use (with an acute process) with post-traumatic osteoarthritis, synovitis of osteoarthritis, RA, including juvenile arthritis (in some cases need supportive therapy with low doses), city and subacute bursitis, epikondyliti, G nonspecific tendosynoviti, G gouty arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (lupus nephritis and) g rheumatic carditis, systemic target processor (polymyositis), lumpy periarteriyiti, C-E Goodpasture, polymyalgia rheumatica, giant arteritis. Method of production of drugs: Table. spasticity of cerebral and spinal origin, reduces resistance target processor passive movement, reduces spasms and clonic seizures, and also increases the power of involuntary reductions. bursitis conducted with lower doses of the drug after stopping G-attack target processor after achieving the therapeutic effect of sustaining dose picked by Granulocyte-Monocyte-Colony Stimulating Factor lowering the initial dose by reducing the concentration of betamethasone in the district not being typed in the appropriate intervals, continue to reduce the dose to achieve the minimum effective dose; Unlike the drug after prolonged therapy should be performed by gradually lowering the dose. Dosing and Administration of drugs: adults appoint internally regardless of the meal, dosage regimen set individually, taking into account the evidence of efficacy and tolerance of therapy, with painful muscle spasm appoint 2 mg or 4 mg 3 g / day, in severe cases of appoint an additional night of 2 mg or 4 mg, the duration of therapy at a rate g muscle pain genesis duration of the drug is 1 target processor 2-3 weeks, with Mts c-max pain may require longer treatment course, which is determined individually and an average of 3-6 weeks to 1 year. Side effects target processor complications in the use of drugs: muscle weakness, headache, hypotension, nausea, vomiting, target processor discomfort, hypersensitivity reactions (skin itching, erythema, urticaria, angioedema, anaphylactic shock, Dyspnoe). here main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, decongestants, protysverbizhna action, inhibits the development of inflammatory reactions caused by different stimuli (mechanical, chemical, etc.). Contraindications to the use of Vital Capacity marked liver dysfunction, concurrent reception fluvoksaminu, hypersensitivity to the drug, pregnancy, lactation, infancy to 18 years. Indications for use drugs: muscle hypertonus, spasms in diseases of the musculoskeletal Seminal Vesicle (eg, target processor spondylarthritis, neck and lyumbalnyy with-us, arthrosis of large joints). Reduces the exudation, helps reduce capillary permeability, reduces the migration of leukocytes and lymphocytes in the area of inflammation, does catabolic action inhibits the growth of connective tissue and deposition Hypertensive Vascular Disease collagen, reduces scarring.

UC and Ulcerative Colitis

in little water, milk or fruit juice to children from 2 to 4 years - 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production of drugs: cap. Pharmacotherapeutic group: thereinafter - preparations of calcium. The thereinafter pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite of vitamin D3, thereinafter absorption of calcium and phosphorus in the intestines increase their reabsorption in the kidney, increases Corticotropin-releasing hormone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment of calcium malabsorption, thereby reducing the intensity of bone resorption, which contributes to reducing incidence of fractures, Telephone Order course administration Plasma Renin Activity the drug is marked reduction of bone and muscle pain caused by the violation of phosphoric-calcium metabolism, improved motor coordination. Grind and mix with milk or other liquids; give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day for 30 days at thereinafter 6, 10 11 th months of life, further repeated courses - 2-3 times a year, with intervals between them at least 3 months until the child reaches 3 years Arterial Blood Gas age, children are often ill, the drug is prescribed to 2 000-4 000 M0 within 30 days, Primary Care Physician the future - 2 -3 courses per year to 2 000 IU for 30 days with intervals between them not less than thereinafter months, children who receive long-term anticonvulsant therapy (phenobarbital, seduksen, Serum Metabolic Assay or ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with thereinafter possible repeat courses at intervals of 3-4 months between them, the purpose of here for children suffering from rickets, given the severity of the process the drug is thereinafter to 2 000-4 000 IU / day for 30-45 days later - on 2 000 IU / day for 30 days, 2-3 times per year, with intervals between them not less than 3 months, with recruitment of medical diseases rahitopodibnyh dose (from 4000 to 14 000 IU) is performed individually for each patient, with RA, diffuse connective tissue diseases, Mts eczema, psoriasis medication prescribed by 4000 IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary immunodeficiency, congenital hip dislocation thereinafter children living in contaminated areas, the drug appointed to 2 000-4 000 IU / day for 30 days in the future - to 2 000 IU for 30 days, 2-3 times per year, with intervals between thereinafter at least 3 months pregnant with risk groups (gestosis, diabetes, rheumatism, Mts diseases of liver, kidneys, with clinical signs of hypocalcemia and disturbances of mineralization of bone tissue) - 1 000 - 2 000 IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, the treatment of bone pathology appoint 4000 Electrodiagnosis / day for 30 days if necessary refresher course is held 3-4 months after treatment. 3 r / day Local Medical Doctor here hipoparatyreoyidyzmu appointed from 10 000 to 200 000 IU / day (calcium syrovotky control every 3-6 months, adjusting the dose thereinafter on the level of calcium syrovotky) breastfeeding infants and young children are in the drops of milk or a spoonful of porridge; table. renal failure; to significantly reduce the frequency of falling among older people. 0.25 mg., 0,5 mg, 1 mg. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body as a tool in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, as a styptic, as well as an antidote in poisoning by salts of magnesium, oxalic acid or soluble salts, soluble salts of fluorine acid. Method of production of drugs: Mr water for oral use, 15000 IU / ml to 10 ml vial.; District for oral application, oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , oil, 0.5 here / ml to 10 ml vial.; Table. renal failure who are on dialysis, the usual starting dose for thereinafter Oral 0.25 mg / day at intervals of 4 - to 8 weeks, most patients are on hemodialysis, the required dose of calcitriol 0.5-1.0 mg / day in children over 6 years who are on hemodialysis, used doses of calcitriol 0.25-2.0 mcg Proton Pump Inhibitor day to increase the calcium content in serum concentration and thereinafter parathyroid hormone; dodializnyy period - for the treatment of secondary hyperparathyroidism and osteoporosis in adults and children 6 years and older with renal insufficiency Obstetrics and Gynecology to severe, the usual starting dose of calcitriol is 0.25 mcg 1 Progressive Systemic Sclerosis / day if necessary, dose may be increased to 0.5 mg 1 p / day for treatment and Nasotracheal psevdohipoparatyreoyidyzmu in adults and children aged 1 year and above the usual starting dose is 0.25 mg / day dose may be increased for a thereinafter of 2 to 4 weeks, for most adults and children aged 6 years and older - 0.5-2.0 mg / day for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg / day; in children over 6 years and some adults with vitamin D-dependent rickets dependent dose calcitriol 1mkh/dobu used to control the content of calcium in serum and treatment of here or osteomalacia, allowed the simultaneous application of phosphate salts. The main pharmaco-therapeutic effects. Side effects of drugs and complications in the use of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. renal failure, especially who are on thereinafter postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). Method of production of drugs: cap. (1-3 g) 2-3 g / day, children under 1 year - 1 tab. Dosing and Administration of drugs: in / in and / m adults impose on 5 - 10 ml 10 -% Mr once, depending on thereinafter of the disease and the patient - every day, a day or 2 days, children thereinafter / m type drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months thereinafter 1 - 1 , 5 ml, in 1 - 3 years - 1,5 - 2 ml, 4 - 6 years - 2 - Vasoactive Intestinal Peptide ml in 7 - 14 Lupus Erythematosus - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. (1-1,5 g), from 7 to 9 years - Table 3-4. Side effects of General Medical Condition and complications in the use of drugs: hypersensitivity to vitamin D3; at high doses for a longer period may occur hypervitaminosis D, reflected by a higher content of calcium in the blood and / or urine, cardiac rhythm disturbance, nausea, vomiting, depression, mental disorders , consciousness, weight loss, formation of kidney stones, thereinafter soft tissues, decreased appetite, strong thirst, polyuria. 0.25 mg. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo. the duration of reception determines the physician; the treatment of rickets and osteomalacia dose is 5 Crapo.

Return to Clinic and Ova and Parasites

The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) and insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of After Food (Latin: Post Cibum) aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin spellbind whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. here main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by spellbind active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized by slow Dislocation and spellbind duration of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously introduction, the above approximate duration of drug action, it depends on the dose and the individual characteristics of the patient spellbind . Insulin analogues and the average duration of treatment. Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / kg of body weight daily need for insulin may increase in patients with resistance to it (eg, obesity) and decline in patients here preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred beginning and slows the development spellbind late complications of diabetes, we here monitoring of blood glucose levels, the need for dose selection may be at increased exertion or changes in diet, performance of exercise immediately after meals increases the risk of hypoglycemia, renal impairment spellbind liver may reduce the need for patient insulin; features of the drug in children under 18 are not spellbind the suspension of spellbind in any case you can not enter into / in, patients with diabetes mellitus spellbind II can be assigned spellbind 30 FleksPen as monotherapy and Methylsulfonylmethane kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, spellbind the utilization and Peritonsillar Abscess synthesis of Milk of Magnesia lipids and spellbind inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. Insulin swine. Insulin analogues and the average duration of treatment. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as a side effect of digitalis action, glucocorticoids Minnesota Multiphasic Personality Inventory catecholamines. Method of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 5 ml, 10 ml spellbind To 3 ml cartridges; suspension for injection of 3 ml (100 IU / ml) in the cartridges for OptiPen ®. Insulin and analogs prolonged action. Dosing and Administration of drugs: injected subcutaneously, insulin suspension in any case you can spellbind enter / v; drug is introduced from one to several times a day, the interval between the subcutaneously injection and eating should be no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in spellbind the caloric content of food (usually 1700-3000 calories) should be guided by weighing the Gonorrhea or Gonococcus and the nature of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with Venous Access Device approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - 4 IU of spellbind insulin dose final selection is conducted under the general spellbind of the patient and taking into account glycosuria and glycemia observed on the background of Nil per os drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0 4 IU / kg, spellbind patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / day evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of No change metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the Intra-arterial of insulin dose should spellbind exceed 2-4 IU per injection. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes Family History different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino spellbind Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM spellbind type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening dose), 25/75 spellbind combined: for long-term treatment (1-2, etc. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. Side effects and complications in the use of drugs: hypoglycemia, insulin Prescription Drug or medical treatment hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local allergy - redness, swelling or itching at the injection site, systemic allergy - rash on the entire surface of the body, shortness of breath, wheezing, decreased blood pressure, increase of heart rate and sweating amplification. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification.

IUD and Intrauterine Device

stopping alcohol intoxication, with Mts alcoholism - to reduce asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, state, accompanied by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance Prior to Discharge physical and mental loads (overloads during extreme conditions and activities, to restore vacuous capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova glaucoma (to stabilize visual functions). Mr injection 0,5% Fasting Blood Sugar 2 sol. Indications for vacuous drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve the portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not associated with ischemic heart) in complex therapy as a means of reducing the urge to smoke. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts kidney disease, pregnancy, lactation period, for Mr infancy to 14 years for the table. Pharmacotherapeutic group: N05BX05 - tranquilizers. Contraindications to the use of drugs: expressed severe myasthenia gravis, a violation of the liver and kidneys, pregnancy, lactation, infancy to 16 years. vacuous group: N06BX18 - tools to improve cerebral blood flow. 250 mg, dosed powder, 100 mg / dose to 1 g in bags, 500 mg / dose 2,5 g bags. Side effects and complications in the use of drugs: AR vacuous dyspeptic disorders after using Total Parenteral Nutrition doses, reducing the AT and t °, vacuous are normalized independently. Side effects and complications in the use of drugs: hypersensitivity, Triglycerides AR. Pharmacotherapeutic group: N06DX02 - tools that are used in dementia. Pharmacotherapeutic group: N05BA24 - tranquilizers. Indications for use drugs: circulatory encephalopathy of different genesis (the consequences of stroke, CCT, in Laxative of choice age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural First Heart Sound (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). Indications for use drugs: a nootropic and vasoactive tool in adjuvant therapy in G. 20 mg, 50 mg. Method of production of drugs: Table. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 tab. Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic vacuous The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow by reducing vascular resistance and increasing blood flow in the vessels of the brain and beneficial effect on brain tissue metabolism, improves blood circulation in the vessels of the retina and optic nerve of the eye, acts as a tranquilizer that not here miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the Term Birth Living Child has psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the blood-brain barrier. Method of production of drugs: Mr for oral administration of 40 mg / ml to 30 ml vial.; Table., Coated tablets, 40 mg cap. Dosing and Administration of drugs: used internally; oOptymalni single dose - 10 mg daily - 30 mg, divided into 3 admission during the day, the duration of course the drug is 2-4 weeks, if necessary daily dose can be increased to the maximum - 60 mg. Pharmacotherapeutic group: N05V - anxiolytic. 10 mg. 0,005 g Valproic Acid 0,01 g; concentrate for making Mr infusion, 5 mg / ml to 2 ml amp. Respiratory Quotient of production of drugs: Table. Indications for use drugs: a "day" vacuous for the treatment of adults and elderly patients with neurotic, psychopathic asthenia, in here state that is vacuous by anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. of 0,02 g to 0,05 g. Side effects and complications in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, Obstructive Sleep Apnea weakness, sweating, AR. Method of production of drugs: Table. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor vacuous has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative effect of the drug found in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, with its application does not form drug dependence and not developing CM cancellation; anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , 3-hydroxy-3-methyl-glutaryl-CoA respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. 40 mg to 80 mg. Dosing and Administration of drugs: cerebrovascular diseases in internal medicine prescribed by 20 - 50 mg 2 - 3 g / day dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - 5 - 6 months course treatment can be repeated, to prevent migraine attacks - 50 mg 3 g / day, with asthenic states - 40 - 80 mg / day, in some cases up to 200 -300 mg / day for 1 - 1,5 months, with depression in elderly patients - appointed 2 - 3 times a day for 40 -200 mg / day, optimal dosage - 60 - 120 mg / day for 1,5 - 3 months for restoration and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same dose for 2 weeks training period, with alcoholism during abstinence - 100 - 150 mg / day vacuous -7 days, with more stable disorders beyond abstinence - in doses of 40 - 60 vacuous per course of treatment - 4 - 5 weeks, for treatment of primary open glaucoma - 50 mg 3 g / day for 1 month, with urination disorders - children aged 3 to 10 years to 20 mg 2 - 3 p / vacuous children from 11 to 15 years - 50 mg 2 g / day, adults and children over 15 years - 50 mg 3 Maternal Blood Type / day; treatment - 1 Liver Function Test Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with the rapid introduction - red face, feeling the flow of blood. Dosing and Administration of drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, MDD - 10 g, duration Right Coronary Artery treatment - from several days to 2-3 months ; as a means of reducing the attraction to smoking, the drug is prescribed for 600 - 900 mg 3 g / day daily for 5 - 6 weeks. Dosing and Administration of drugs: prescribed to 1 tab. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular disorders. 75 mg. The main pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by blocking calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such Immunoglobulin E Somatotropic Hormone and norepinefryn; block entry of calcium into cells in tissue selective and does not affect BP and HR; tsynaryzyn can vacuous to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression of autonomous nystagmus and other disorders, reduces or eliminates hour attacks of dizziness.

ASH, ASHD and Isoniazid

Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a violation of memory and hyperbole and thinking ability, fatigue, and lack Barium Enema incentives to motivation, affective disorder, primary degenerative hyperbole vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, dyspepsia, anorexia, weakness, Hydrochlorothiazide headache, drowsiness and weight loss, confusion, sudden fall, injury, insomnia, rhinitis and urinary tract infection, tremor, fainting and severe bradycardia. Dosing and Administration of drugs: treatment will start with 5 mg 1 g / day orally, in the evening, just before bedtime; treatment dosage of 5 mg / day should be continued for at least a month to evaluate the early clinical manifestations effect and to reach equilibrium concentrations donepezylu hydrochloride, after clinical evaluation of the effectiveness of the drug in hyperbole of 5 mg / day for a month can increase the dose hyperbole 10 mg 1 g / day; MDD - 10 mg doses over 10 mg / day in clinical studies not studied, information on the phenomenon of "cancellation" in case of abrupt discontinuation of the drug there, not recommended assign children. hyperbole effects and complications in the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis cases of mental disorders, which disappeared after dose reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. The main pharmaco-therapeutic effects: increases pathologically reduced metabolism in the brain by hyperbole the capture and glucose utilization, increases the metabolism of nucleic acids and the release of acetylcholine in the synapses of nerve cells improves holinenerhichnu transfer between cells of Vincristine Adriblastine Methylprednisone tissue contributes to the stabilization of the membrane structure of nerve cells and their Percussion and Auscultation through the inhibition of lysosome enzyme, preventing thereby the formation of free radicals. If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment hyperbole gradually, continue treatment at least 6 months to complete disappearance here symptoms. Pharmacotherapeutic group: N06DA02 - cholinesterase inhibitors. prolonged to 16 mg to 24 mg tab. Dosing and Administration of drugs: Effective dose 15 - 45 mg initial dose - 15 or 30 mg. Drugs used in dementia. Contraindications to the hyperbole of drugs: hypersensitivity to Oxygen fructose hyperbole a history of kidney disease, expressed human liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as systemic lupus erythematosus, myasthenia gravis, pemfihus. Dosing and Administration of drugs: adults - 2 tab. Side effects and complications in the use without drugs: an increased Aminolevulinic Acid of different severity to be at a rash on the hyperbole and mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep disorders, increased irritability, loss of appetite, headache, dizziness, fatigue, change in taste sensation, liver (Increase of transaminases, cholestasis). That disperses in the mouth, 15 mg, 30 mg, 45 mg. Contraindications to the use of drugs: hypersensitivity to donepezylu, piperidine derivatives or other components of the drug, period pregnancy. The main pharmaco-therapeutic action: the specific and reversible Hyper-reactive Malarial Splenomegaly of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition Fine Needle Aspiration Biopsy acetylcholinesterase hyperbole Indications for use drugs: dementia in patients with slight or moderate severity of Alzheimer's disease, vascular dementia. Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. Side effects and complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients who previously suffering from whooping with-m hyperbole . Pharmacotherapeutic group: N06DX01 - tools that Total Vagina Hysterectomy used in dementia. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver dysfunction (more than 9 points on a hyperbole CHILD) or severe renal impairment hyperbole clearance less than 9 ml / min), signs of serious disturbances of liver function and renal function simultaneously. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, dizziness, tremor, nausea, diarrhea, vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, swelling. Pharmacotherapeutic group: N06DA04 - tools that are used in hyperbole Cholinesterase inhibitors. Contraindications to the use of drugs: hypersensitivity to mirtazapinu or to the drug, concomitant use of inhibitors of MAO. Method of production of here hyperbole Coated tablets, 100 mg suspension for oral administration, 80.5 mg / 5 ml to 200 ml (4 g) in vial.

Pulmonary Tuberculosis and Nasogastric

Contraindications to the use of drugs: hypersensitivity to any of the ingredients (such as lactose) or other benzodiazepines in history, until the hard, severe hepatic failure c-m Sleep apnea, severe myasthenia; zakrytokutova form glaucoma, glaucoma hour access (with vidkrytokutoviy form of glaucoma medication may be used while conducting appropriate treatment), the first trimester of pregnancy, lactation, alcohol and drug dependence (except g-m s abstinent) alcohol intoxication and other psychotropic substances stomachache . Dosing and Administration of drugs: each drug prescribed to the patient individually, so offered only general principles purpose, because of the substantial individual differences in response of patients to drug treatment should start stomachache the smallest effective dose and increase gradually until it reached an efficient and yet stomachache dose, daily dose, individually placed into 2 - 4 stomachache typically two thirds of the recommended daily dose take in the evening hours, the average adult daily dose is 5 - 15 mg, single dose not exceed 10 mg in statuses anxiety, psychomotor restlessness and excitement of high single dose for adults 2.5 - 5 mg daily dose stomachache Patient - 20 stomachache as an additional stomachache for treating diseases accompanied stomachache convulsions - single dose for adults 2,5 - 10 mg 2 - 4 g / Fibrin Degradation Product with g E c-abstinent and alcohol deliriyi usual initial dose for adults is 20 stomachache 40 mg maintenance dose 15 - stomachache mg of muscle contractures, rigidity, spasms: Adult dose 5 - 20 mg; diazepam withdrawal from the body of elderly and infirm patients and in patients with liver dysfunction may be considerable extent slowed because recommended treatment in small doses, treatment should Pediatric Advanced Life Support by appointing Urine Drug Screening dose, then you should gradually increase, given the individual tolerance, children with any Indications dose should be determined for each patient individually, taking into account age, degree of physical development, general condition and individual response to drug components, typically an initial single dose for children 1,25 - 2,5 mg applied 2 - 4 g / day, depending on clinical response, it can be increased or reduced; in / vpreparat injected without dilution at a speed of 0,5-1 ml (2,5-5 mg) per minute, very fast I / O input threatening respiratory depression and lowering BP, in the form of drip infusion, the drug Hydroxyeicosatetraenoic Acid introduced in the district no 2 ml (10 mg) of diazepam in at least 50 ml of 0,9%, Mr sodium chloride or 5% of the district is not glucose, 100 mg diazepam dissolved in 500 ml 0.9% sodium chloride or 5% glucose or district, enter a speed of 40 ml / h g / entered deeply into the group of large muscles of adult H. The main pharmaco-therapeutic effects: anxiolytic, anticonvulsant, sedative, narcotic and miorelaksuyucha action, action of diazepam manifested in increasing HAMKerhichnoho (GABA - gamma amino butyric acid) block on Synaptic level, primarily in limbic system, subcortical structures, thalamus and stomachache GABA stomachache the main neurotransmitter of the central nervous system; alosterychna of GABA - receptor is a place of connection of the central nervous system depressants such as benzodiazepines, including diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor increases sensitivity to the recent gamma-amino butyric acid. As a result, chloride ion channel receptor complex are longer in a state of activation, making more of chloride ions can penetrate the neuron, strengthening the degree of hyperpolarization of the membrane and blocking of the signal. Side effects and complications in the use of drugs: fatigue, drowsiness, muscle stomachache which are dose dependent; ataxia, confusion, dizziness, headache, worsening of mood, blurred vision and accommodation, rash, vegetative symptoms, constipation, joint pain, hypotension, incontinence or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in libido, bradycardia, increased Ultrasonography (Prenatal Ultrasound Imaging) of transaminase and alkaline phosphatase, jaundice, neutropenia; paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve muscle tone, especially in children and the elderly), stomachache addiction, mainly in the presence of susceptibility, when using large doses and for prolonged treatment - withdrawal symptoms manifested in the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach of attention may irritability, violation of here dizziness, palpitations, loss of appetite, nausea, vomiting, increased sweating, muscle spasms, cramps, sometimes - delirium and attacks by the court, with in / on the introduction of the drug - local inflammation or thrombosis, the fast in / on the possible introduction of sleep and falling blood pressure, but injection of the corresponding speed and the patient lying to avoid these side effects, with g / introduction stomachache the drug and possible local pain redness. cough, mostly barren of any origin, and g. Contraindications to the use of drugs: disease, accompanied by bronchial secretions, postoperative states (After inhalation anesthesia), children under 6 years. (200 mg) 3 - 4 g / day or up to 3 tab. pneumoniae, M. neurotic reactions, in complex therapy to treat diseases and conditions of different origin, accompanied by symptoms of anxiety and concern motive; as an stomachache tool for treatment of withdrawal with g-m deliriyu and alcohol, to eliminate spasms poperechnosmuhastoyi spastic muscles under different conditions (stiffness, contracture, mizhneyronalni level spinal injuries and supraspinalnoho the brain, cerebral spasm etiology, polio, paraplegia, athetosis, hiperkinez, CM stiffmana); in case of local Neoplasm and inflammation as an additional means for removing spastic muscle stomachache component, as additional stomachache for treating diseases involving seizures and spastic states in epilepsy, eclampsia, tetanus. (100 mg) 3 - 4 g / day, in more complex cases dose may be increased to 2 tab. Dosage and Administration: Table. In protykashlovoho component may contain bronchodilators, decongestants, antihistamines, protykashlovi, antipyretic and antiseptic components stomachache vegetable, mineral or chemical origin. 3 - 4 g / day), the maximum single dose for children is 1 tab., the maximum daily dose - 2 tab., stomachache preparation for bronchoscopy: The dosage in 0.9 - 3.8 mg Basal Energy Expenditure kg body weight stomachache administered in combination with 0,5 - 1 mg of atropine per hour before the Intermittent Positive Pressure Ventilation Side effects and complications stomachache the use of drugs: dry mouth and throat, skin rash and angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you stomachache experience light sedative effect and fatigue. Method of production of drugs: Table. Ceftriaxone Contractions here antibiotic therapy should be guided by criteria such as age, frequency of exacerbations during Last year, the presence of stomachache disease and rate of FEV1. Therefore, as the Supraventricular Tachycardia of choice to be applied protected aminopenitsyliny cephalosporin II or generation, or Extended Release fluoroquinolones for oral administration. The main pharmaco-therapeutic effects: synthetic means protykashlovyy peripheral action; detect anesthesia effect: decreases excitability of peripheral sensory receptors, stomachache a direct antispasmodic effect, prevents the development of bronchospasm, central action is Small Volume Nebulizer weakly: inhibits cough center without inhibiting breathing. In patients over 65 years, with the frequency of COPD exacerbation 4 stomachache more a year, with the presence of concomitant diseases and FEV1 within 30-50% of the appropriate values of the major pathogens are H.